Latest News

A new report has suggested that women suffering from female sexual dysfunction (FSD) are being prevented from seeking help due to societal and cultural barriers...

Good news for BioSante, a company conducting trials into a new treatment for female sexual dysfunction called Libigel...

The pharmaceutical firm Vivus has announced that their chief executive officer Leland Wilson will present an overview of the company next week, where they are expected to give an update on a variety of new treatments, including a product to combat hypoactive sexual desire disorder in women...

Valentine’s Day has just been and across the world, millions of men tried to charm the women in their life with extravagant gifts of chocolate...

Boehringer Ingelheim, the drugs company researching the potential of the new medication flibanserin, are currently recruiting women suffering from hypoactive sexual desire disorder (HSDD) to take part in clinical trials into the drug in the US...